|
rs6265
|
|
|
0.030 |
GeneticVariation |
BEFREE |
We conclude that the BDNF Val66Met polymorphism influenced responses to add-on memantine by decreasing depressive symptoms in patients with BP-II.
|
24103632 |
2014 |
|
rs759834365
|
|
|
0.030 |
GeneticVariation |
BEFREE |
We conclude that the BDNF Val66Met polymorphism influenced responses to add-on memantine by decreasing depressive symptoms in patients with BP-II.
|
24103632 |
2014 |
|
rs6265
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Logistic regression analysis showed a significant effect of the COMT and the BDNF polymorphisms, and a significant interaction effect for the Val/Val genotypes of the BDNF Val66Met polymorphism and the COMsT Val158Met Val/Met and Met/Met genotypes (P=0.007, 0.048) discriminated between BP-II without AD patients and controls.
|
23026378 |
2013 |
|
rs759834365
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Logistic regression analysis showed a significant effect of the COMT and the BDNF polymorphisms, and a significant interaction effect for the Val/Val genotypes of the BDNF Val66Met polymorphism and the COMsT Val158Met Val/Met and Met/Met genotypes (P=0.007, 0.048) discriminated between BP-II without AD patients and controls.
|
23026378 |
2013 |
|
rs6265
|
|
|
0.030 |
GeneticVariation |
BEFREE |
We provide initial evidence that the BDNF Val66Met and DRD3 Ser9Gly genotypes interact only in bipolar-II disorder and that bipolar-I and bipolar-II may be genetically distinct.
|
22877924 |
2012 |
|
rs759834365
|
|
|
0.030 |
GeneticVariation |
BEFREE |
We provide initial evidence that the BDNF Val66Met and DRD3 Ser9Gly genotypes interact only in bipolar-II disorder and that bipolar-I and bipolar-II may be genetically distinct.
|
22877924 |
2012 |
|
rs6280
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder.
|
27310943 |
2016 |
|
rs4680
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Logistic regression analysis showed a significant interaction effect of the COMT Val158Met Val/Val genotype and the MTHFR C677T C/T + T/T genotype (P = 0.039) for the protective effect on the odds of developing BP-II.
|
25744938 |
2015 |
|
rs4680
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Logistic regression analysis showed a significant effect of the COMT and the BDNF polymorphisms, and a significant interaction effect for the Val/Val genotypes of the BDNF Val66Met polymorphism and the COMsT Val158Met Val/Met and Met/Met genotypes (P=0.007, 0.048) discriminated between BP-II without AD patients and controls.
|
23026378 |
2013 |
|
rs6280
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We provide initial evidence that the BDNF Val66Met and DRD3 Ser9Gly genotypes interact only in bipolar-II disorder and that bipolar-I and bipolar-II may be genetically distinct.
|
22877924 |
2012 |
|
rs5443
|
|
|
0.010 |
GeneticVariation |
BEFREE |
At baseline, the GNB3 C825T polymorphisms were associated with the triglyceride level (P=0.032) in BP-II patients.
|
26856249 |
2017 |
|
rs1200746244
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Logistic regression analysis showed a significant interaction effect of the COMT Val158Met Val/Val genotype and the MTHFR C677T C/T + T/T genotype (P = 0.039) for the protective effect on the odds of developing BP-II.
|
25744938 |
2015 |
|
rs1217691063
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Logistic regression analysis showed a significant interaction effect of the COMT Val158Met Val/Val genotype and the MTHFR C677T C/T + T/T genotype (P = 0.039) for the protective effect on the odds of developing BP-II.
|
25744938 |
2015 |
|
rs749437638
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Logistic regression analysis showed a significant interaction effect of the COMT Val158Met Val/Val genotype and the MTHFR C677T C/T + T/T genotype (P = 0.039) for the protective effect on the odds of developing BP-II.
|
25744938 |
2015 |
|
rs5848
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The presence of the polymorphic variant of the rs5848 single nucleotide polymorphism is protective for the development of bipolar I disorder (BD-I) (odds ratio = 0.55, 95% confidence interval: 0.33-0.93; p = 0.024) but not bipolar II disorder (BD-II) (p > 0.05).
|
24499389 |
2014 |
|
rs893924483
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Logistic regression analysis showed a significant effect of the COMT and the BDNF polymorphisms, and a significant interaction effect for the Val/Val genotypes of the BDNF Val66Met polymorphism and the COMsT Val158Met Val/Met and Met/Met genotypes (P=0.007, 0.048) discriminated between BP-II without AD patients and controls.
|
23026378 |
2013 |
|
rs956572
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Basal intracellular Ca(2+) concentrations ([Ca(2+) ](B) ) and rs956572 genotypes were determined in B lymphoblast cell lines (BLCLs) from bipolar I disorder (BD-I) (n=150), bipolar II disorder (BD-II) (n=65), and major depressive disorder (n=30) patients, and from healthy subjects (n=70).
|
21320251 |
2011 |
|
rs6484218
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The strongest result was seen for a single nucleotide polymorphism near the adrenomedullin (ADM) gene (rs6484218), with the best-fitting model indicating that the effect was specific to bipolar II disorder.
|
20713499 |
2010 |